See Full Document Text
Status: This is the original version (as it was originally made). This
item of legislation is currently only available in its original format.
STATUTORY INSTRUMENTS
2026 No. 23
CONSUMER PROTECTION
The Cosmetic Products Regulation (EC) No 1223/2009
(Restriction of Chemical Substances) (Amendment
and Transitional Provisions) Regulations 2026
Made - - - - 12th January 2026
Laid before Parliament 15th January 2026
Coming into force in accordance with regulation 1(2)
and (3)
The Secretary of State makes these Regulations in exercise of the powers conferred by Articles 31(1)
(b), 31(1)(f) and 32(1) of Regulation (EC) No 1223/2009 of the European Parliament and of the
Council on cosmetic products(1) (“the Cosmetic Regulation”).
In accordance with Article 31(1)(b) of the Cosmetic Regulation, the Secretary of State considers
there is sufficient scientific evidence that there is a potential risk to human health arising from the
use of 3-(4'-methylbenzylidene)-camphor in a cosmetic product and from the current threshold for
warning labelling requirements for formaldehyde releasing preservatives listed in Annex 5 to the
Cosmetic Regulation.
In accordance with Article 31(1)(f) of the Cosmetic Regulation, the substances set out in the
Schedule to these Regulations have been classified as CMR(2) substances of category 1B or 2 under
Regulation (EC) No 1272/2008 of the European Parliament and of the Council on classification,
labelling and packaging of substances and mixtures(3).
Citation, commencement, extent and interpretation
1.—(1) These Regulations may be cited as the Cosmetic Products Regulation (EC) No 1223/2009
(Restriction of Chemical Substances) (Amendment and Transitional Provisions) Regulations 2026.
(2) Subject to paragraph (3), these Regulations come into force on 15th July 2026.
(3) Regulation 2(3) comes into force on 15th August 2026.
(4) These Regulations extend to England and Wales and Scotland.
(1) EUR 2009/1223; relevant amending instruments are S.I. 2022/659, S.I. 2023/836, S.I. 2024/1334, S.I. 2025/901.
(2) For the definition of “CMR” see Article 2(1)(va) of the Cosmetic Regulation.
(3) EUR 2008/1272, to which there are amendments not relevant to these Regulations.Document Generated: 2026-01-15
Status: This is the original version (as it was originally made). This
item of legislation is currently only available in its original format.
(5) In these Regulations “the Cosmetic Regulation” means Regulation (EC) No 1223/2009 of the
European Parliament and of the Council on cosmetic products.
Amendments to the Cosmetic Regulation
2.—(1) The Cosmetic Regulation is amended as follows.
(2) At the end of the table in Annex 2 (list of substances prohibited in cosmetic products) insert—
“1744 3-(4’- 38102-62-4/36861-47-9253-242-6”.
methylbenzylidene)-
camphor
(3) In the table in Annex 2, after the entry inserted by regulation 2(2), insert the entries set out
in the Schedule to these Regulations.
(4) In paragraph 2 of the Preamble to Annex 5 (list of preservatives allowed in cosmetic products)
—
(a) for “contains” substitute “releases”; and
(b) for “0,05” substitute “0.001”.
(5) In the table in Annex 6 (list of UV filters allowed in cosmetic products), omit the entry at
reference number 18 (3-(4-Methylbenzylidene)-d1 camphor/Enzacamene).
Transitional Provisions
3. Despite the amendments made—
(a) by regulation 2(2), (4) and (5) of these Regulations, a cosmetic product placed on the
market before 15th July 2026 may continue to be made available on the market until the
end of 14th January 2027 if it—
(i)contains the substance inserted into Annex 2 to the Cosmetic Regulation by
regulation 2(2) and omitted from Annex 6 to the Cosmetic Regulation by
regulation 2(5); and
(ii)is labelled in accordance with the requirements set out in paragraph 2 of the Preamble
to Annex 5 to the Cosmetic Regulation, as it has effect before 15th July 2026;
(b) by regulation 2(3) of these Regulations, a cosmetic product placed on the market before
15th August 2026 containing any of the substances inserted into Annex 2 to the Cosmetic
Regulation by regulation 2(3) may continue to be made available on the market until the
end of 14th February 2027.
Kate Dearden
Parliamentary Under-Secretary of State
12th January 2026 Department for Business and Trade
2Document Generated: 2026-01-15
Status: This is the original version (as it was originally made). This
item of legislation is currently only available in its original format.
Schedule Regulation 2(3)
Entries to be inserted into Annex 2
“1745 Diphenyl(2,4,6- 75980-60-8 278-355-8
trimethylbenzoyl)phosphine
oxide
1746 clothianidin (ISO); 210880-92-5 433-460-1
(E)-1-(2-chloro-1,3-
thiazol-5-ylmethyl)-3-
methyl-2-
nitroguanidine
1747 Dimethyl 18755-43-6 242-555-3
propylphosphonate
1748 Dibutyltin maleate 78-04-6 201-077-5
1749 Dibutyltin oxide 818-08-6 212-449-1
1750 2,2’, 6,6’- 79-94-7 201-236-9
tetrabromo-4,4’-
isopropylidenediphenol;
tetrabromobisphenol-
A
1751 1,4-Benzenediamine, 68953-84-4 273-227-8
N,N'-mixed Ph and
tolyl derivs.
1752 4-Methylimidazole 822-36-6 212-497-3
1753 Acetone Oxime 127-06-0 204-820-1
1754 Benthiavalicarb 177406-68-7
isopropyl (ISO);
isopropyl [(S)-1-
{[(R)-1-(6-fluoro-1,3-
benzothiazol-2-
yl)ethyl]carbamoyl}-2-
methylpropyl]carbamate
1755 2,3-epoxypropyl 26761-45-5 247-979-2
neodecanoate
1756 Multi-walled carbon
tubes (synthetic
graphite in tubular
shape) with a
geometric tube
diameter range ≥ 30 nm
to < 3 µm and a length
≥ 5 µm and aspect
ratio > 3:1, including
Multi-Walled Carbon
Nanotubes, MWC(N)T
3Document Generated: 2026-01-15
Status: This is the original version (as it was originally made). This
item of legislation is currently only available in its original format.
1757 7- 2386-87-0 219-207-4
oxabicyclo[4.1.0]hept-3-
ylmethyl 7-
oxabicyclo[4.1.0]heptan-3-
carboxylate
1758 2-(dimethylamino)-2- 119344-86-4 438-340-0
[(4-
methylphenyl)methyl]-1-
[4- (morpholin-4-
yl)phenyl]butan-1-one
1759 S-metolachlor (ISO); 87392-12-9
2-chloro-N-(2-ethyl-6-
methylphenyl)-N-
[(2S)-1-
methoxypropan-2-
yl]acetamide; (R a
S a)-2-chloro-N-(6-
ethyl-o-tolyl)-N-
[(1S)-2-methoxy-1-
methylethyl]acetamide
[contains 80-100 % 2-
chloro-N-(2-ethyl-6-
methylphenyl)-N-
[(2S)-1-methox-
ypropan-2-
yl]acetamide and 0-20
% 2-chloro-N-(2-
ethyl-6-
methylphenyl)-N-
[(2R)-1-
methoxypropan-2-
yl]acetamide]
1760 Trimethyl borate 121-43-7 204-468-9”
EXPLANATORY NOTE
(This note is not part of the Regulations)
Following advice from the Scientific Advisory Group on Chemical Safety of Non-Food and
Non-Medicinal Consumer Products that there is a potential risk to human health from the use
of certain chemical substances in cosmetic products, these Regulations amend Regulation (EC)
No 1223/2009 (“the Cosmetic Regulation”). Specifically, regulation 2(2) amends Annex 2 to the
Cosmetic Regulation (list of substances prohibited in cosmetic products) (“Annex 2”) to prohibit
the use of 3-(4'-methylbenzylidene)-camphor in cosmetic products. Regulation 2(4) amends the
Preamble to Annex 5 (list of preservatives allowed in cosmetic products) to the Cosmetic Regulation
4Document Generated: 2026-01-15
Status: This is the original version (as it was originally made). This
item of legislation is currently only available in its original format.
to reduce the threshold for warning labelling requirements for formaldehyde releasing preservatives
used in cosmetic products. These amendments apply from 15th July 2026.
Regulation 2(3) and the Schedule further amend Annex 2 to add substances that have been classified
as category 1B or 2 carcinogenic, mutagenic or toxic for reproduction (“CMR”) substances under
Regulation (EC) No 1272/2008, prohibiting these substances from use in cosmetic products. This
amendment applies from 15th August 2026.
Regulation 3 sets out the transitional arrangements for cosmetic products containing these
substances.
A full impact assessment has not been produced for this instrument as no, or no significant, impact
on the private, voluntary or business sectors is foreseen. An Explanatory Memorandum is published
alongside these Regulations on www.legislation.gov.uk.
5